CYCLOREA: Effect of Virtual Reality Combined With Cycloergometer Versus Conventional Cycloergometer on Distance Covered for Intensive Care Unit Non-sedated Participants

Sponsor
Centre Hospitalier Régional d'Orléans (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05952180
Collaborator
(none)
28
1
2
12
2.3

Study Details

Study Description

Brief Summary

Management in intensive care unit (ICU) has gradually evolved to early mobilization. Studies have confirmed a 50% decrease impact on the functional abilities and quality of life after ICU. The cycloergometer is particularly studied and effective for early rehabilitation. Current practices encounter obstacles as fatigue, pain or a lack of motivation to mobilize. Several studies have been carried out to evaluate the effects of virtual reality (VR) on mental health and on cognitive abilities. To date, there is little evidence about VR on distraction and the impact on physical activity motivation in ICU.

The main hypothesis is that the use of combine cycloergometer and VR would improve the travelled distance by patients in ICU. Adverse effects would be observed initially in order to consolidate the safety data of this device. It would also allow a better participant experience.

Condition or Disease Intervention/Treatment Phase
  • Device: Virtual reality and Cycloergometer
  • Other: Standard cycloergometer
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
28 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Intervention Model Description:
Monocentric cross-over trial comparing the combination of cycloergometer and virtual reality to standard cycloergometer, in ICU, over the actively covered distance in kilometers.Monocentric cross-over trial comparing the combination of cycloergometer and virtual reality to standard cycloergometer, in ICU, over the actively covered distance in kilometers.
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Effect of Virtual Reality Combined With Cycloergometer Versus Conventional Cycloergometer on Distance for ICU Non-sedated Participants: Prospective Randomized Controlled Trial
Anticipated Study Start Date :
Oct 1, 2023
Anticipated Primary Completion Date :
Oct 1, 2024
Anticipated Study Completion Date :
Oct 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Virtual reality and Cycloergometer

The session performed uses a standard cycloergometer, with the participant pedaling in a seated position with the lower limbs. A 43 inches TV screen is placed in front of the cycloergometer where the participant will watch a video of a walk through a natural environment on. The speed of the walk is linked to the pedaling speed so that the faster the participant pedals, the faster the video goes too. The session last 30 minutes in the participant's room.

Device: Virtual reality and Cycloergometer
The session performed uses a standard cycloergometer, with the participant pedaling in a seated position with the lower limbs. A 43 inches TV screen is placed in front of the cycloergometer where the participant will watch a video of a walk through a natural environment on. The speed of the walk is linked to the pedaling speed so that the faster the participant pedals, the faster the video goes too. The session last 30 minutes in the participant's room.

Active Comparator: Standard cycloergometer

For the "standard cycloergometer" intervention, the session uses usual cycloergometer with the participant pedaling in a seated position with the lower limbs. No virtual reality is used. The session last 30 minutes in the participant's room

Other: Standard cycloergometer
the session uses usual cycloergometer with the participant pedaling in a seated position with the lower limbs. The session lats 30 minutes in the participant's room.

Outcome Measures

Primary Outcome Measures

  1. Distance actively covered (in kilometers with one decimal) [Day 2]

    Distance actively covered (in kilometers) with the combination of virtual reality and cycloergometer versus distance actively covered (in kilometers with one decimal) with conventional seated cycloergometer session

Secondary Outcome Measures

  1. Number of adverse effects noted during the session [Day 2]

    Compare between the two cross-over groups the adverse effects noted during the session

  2. Measure of patient's experience with Visual Analogic Scale (on /10) [Day 2]

    Compare between the two cross-over groups - the patient's experience of "perception of effort", "sensation of escape from the virtual reality" and "motivation to a next session"

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Over 18 years old hospitalized in the surgical intensive care unit (USC or reanimation) of the Centre Hospitalier Régional d'Orléans

  • Glasgow 15

  • Satisfying the chair installation criteria before the inclusion

  • With or without :

  • any type of invasive or non-invasive ventilation

  • any type of oxygenation

  • Stable within its medically determined target parameters

  • Hemodynamically stable (MAP>65)

Exclusion Criteria:
  • Person presenting a medical contraindication to cycloergometer

  • Person under guardianship or curatorship

  • Person under court protection

  • Stay less than 48 hours (post-neurosurgery surveillance)

  • Persons weighing over 180 kg

  • Person not affiliated to a social security system

  • Pregnant or breast-feeding Women

  • Deaf and visually impaired people

  • Patient included in another study with the same endpoint

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHR d'Orléans Orléans France 45067

Sponsors and Collaborators

  • Centre Hospitalier Régional d'Orléans

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Centre Hospitalier Régional d'Orléans
ClinicalTrials.gov Identifier:
NCT05952180
Other Study ID Numbers:
  • CHRO-2023-03
First Posted:
Jul 19, 2023
Last Update Posted:
Jul 21, 2023
Last Verified:
Jul 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Centre Hospitalier Régional d'Orléans

Study Results

No Results Posted as of Jul 21, 2023